É uma inflamação que atinge os nervos e faz parte do conjunto de problemas relacionados à Síndrome de Guillain-Barré (SGB).
Introdução
O que você precisa saber de cara
É uma inflamação que atinge os nervos e faz parte do conjunto de problemas relacionados à Síndrome de Guillain-Barré (SGB).
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 7 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 13 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.
Seems to be involved in pore-forming activity and may contribute to the unspecific permeability of the peroxisomal membrane
Peroxisome membrane
Medicamentos aprovados (FDA)
1 medicamento encontrado nos registros da FDA americana.
Variantes genéticas (ClinVar)
292 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
2 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Polirradiculoneuropatia inflamatória aguda (aidp)
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
89 ensaios clínicos encontrados, 4 ativos.
Publicações mais relevantes
Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.
Electrophysiological subtypes of Guillain-Barré Syndrome (GBS) vary in pathophysiology and clinical presentation, but comparative data on their intensive care needs in critically ill children remain limited. In this retrospective cohort study, we analyzed 224 children (1 month to 12 years) diagnosed with GBS and admitted to the Pediatric Intensive Care Unit of a tertiary care hospital in North India from January 2010 to December 2022. GBS was subtyped based on nerve conduction studies into acute motor axonal neuropathy (AMAN), acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor-sensory axonal neuropathy (AMSAN), inexcitable, or equivocal patterns. Clinical features, intensive care interventions, and outcomes were compared across subtypes. AMAN was the most common subtype (61.6%), followed by AIDP (20.1%) and AMSAN (8%). A prodromal illness was reported in 47.3% of cases. Mechanical ventilation was required in 54.9%, and tracheostomy in 24.2% of children. AMSAN was associated with a significantly longer duration of symptoms at presentation (P = 0.006). Autonomic instability, particularly hypertension (P = 0.04), was significantly more frequent in the AIDP group. However, Hughes disability scores, respiratory and cranial nerve involvement, and intensive care needs were similar across subtypes. AMAN was the predominant GBS subtype in critically ill children. While AMSAN was associated with delayed presentation and AIDP with greater autonomic dysfunction, overall intensive care needs and short-term outcomes were comparable across subtypes.
Case Report: Complete remission of Guillain-Barré syndrome in neuropsychiatric lupus with telitacicept.
Neuropsychiatric systemic lupus erythematosus (NPSLE) manifesting as Guillain-Barré syndrome (GBS) is exceptionally rare, with only 28 documented cases in medical literature, and current biological therapies show limited efficacy. We report a 34-year-old woman who presented with progressive quadriparesis, bilateral ptosis, and facial palsy developing over one month. Laboratory investigations revealed marked B-cell dysregulation with elevated immunoglobulin G (24.30 g/L, normal 7-16), positive antinuclear antibodies (1:320), anti-double-stranded DNA antibodies (128 IU/ml, normal <20), anti-ribosomal P antibodies (450 AU/ml, normal <20), and hypocomplementemia (C3 1.10 g/L, C4 0.28 g/L). Cerebrospinal fluid analysis showed cytoalbuminologic dissociation (protein 1314 mg/L, cells 1×106/L), and nerve conduction studies confirmed acute inflammatory demyelinating polyradiculoneuropathy. Following inadequate response to intravenous immunoglobulin monotherapy, combination treatment was initiated with methylprednisolone (40mg daily), cyclophosphamide (0.6g biweekly), hydroxychloroquine, and telitacicept (160mg weekly), a novel dual inhibitor of B lymphocyte stimulator and a proliferation-inducing ligand that simultaneously targets B cells and plasma cells. At six-month follow-up, the patient achieved complete neurological recovery with significant laboratory improvements: immunoglobulin G decreased 61.6% to 9.34 g/L, anti-double-stranded DNA antibodies decreased 82.8% to 22 IU/ml, erythrocyte sedimentation rate normalized from 63 to 8 mm/h, and complement levels recovered. Corticosteroids were successfully tapered to 4mg daily without disease flare. This first report of telitacicept use in NPSLE-GBS demonstrates that dual BLyS/APRIL inhibition can achieve complete remission in refractory cases, offering a promising therapeutic approach that warrants further investigation in controlled trials.
Acute Inflammatory Demyelinating Polyradiculoneuropathy-like Associated with Subcutaneous Foslevodopa-Foscarbidopa: First Report.
Polyradiculoneuropathies associated with immune checkpoint inhibitors: are we facing a new nosological entity?
Immune checkpoint inhibitors (ICIs) like ipilimumab, nivolumab, and pembrolizumab are increasingly used to treat advanced cancers. While they improve survival, they can cause immune-related adverse events (irAEs), including neurological issues affecting the peripheral nervous system (PNS). Among these, peripheral neuropathies such as acute inflammatory demyelinating polyneuropathy (AIDP) and chronic inflammatory demyelinating polyneuropathy (CIDP) are common. Diagnosing these conditions can be difficult, especially when caused by ICIs, leading to potential misclassification and suboptimal treatment. A 48-year-old woman with melanoma on pembrolizumab developed progressive weakness, sensory disturbances, and areflexia after two cycles of treatment. Neurological evaluation suggested AIDP, and she was treated with intravenous immunoglobulin (IVIg), which led to initial improvement. However, 60 days later, she relapsed with widespread weakness, and her condition was reclassified as acute-onset CIDP (A-CIDP). This case illustrates the challenge of distinguishing ICI-related AIDP from A-CIDP and the importance of accurate, early diagnosis and treatment. A review of the Literature found 51 AIDP and 10 CIDP cases related to ICIs. Symptoms commonly included weakness, paresthesia, and gait instability, with electromyography and nerve conduction studies often showing demyelinating patterns. Most patients were treated with steroids or IVIg, with significant recovery, though some AIDP cases relapsed or progressed, resembling A-CIDP. This highlights the risk of misdiagnosis in patients with ICI-related AIDP/CIDP. This case underscores the complexities of diagnosing ICI-related neuropathies, especially A-CIDP. Early cessation of ICI therapy and prompt immunosuppressive treatment are essential to prevent long-term disability.
Plasma periaxin is a biomarker of peripheral nerve demyelination.
Assessing disease progression and informing clinical trials in peripheral neuropathy would benefit from objective and responsive fluid biomarkers closely linked to disease biology. This is particularly important in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and Guillain-Barré syndrome (GBS), the most common inflammatory neuropathies, where reliable biomarkers of peripheral demyelination would help identify, and potentially measure, active disease and responses to treatment. We postulated that periaxin, a protein exclusively expressed by myelinating Schwann cells, could serve as a fluid biomarker of demyelinating peripheral neuropathy. We developed a single molecule array (Simoa)-based immunoassay to measure plasma periaxin in patients with CIDP (n = 45, including longitudinal samples across a discovery cohort and a validation cohort, for a total of 77 time points), GBS (n = 30, 66 time points), Charcot-Marie-Tooth disease (CMT, n = 20), CNS disease controls with multiple sclerosis (n = 30) and healthy controls (n = 30). We also evaluated whether periaxin is released in myelinating co-cultures following immune-mediated demyelination and axonal damage, comparing results with uninjured cultures. Plasma periaxin effectively distinguishes peripheral from CNS diseases, with significantly elevated levels in CIDP, GBS and CMT, but not in CNS disease or healthy controls (all P < 0.01). In CIDP, periaxin discriminates patients with active disease from those with inactive disease (P < 0.0001), and plasma levels decrease following treatment with intravenous immunoglobulin (IVIg). Elevated periaxin strongly predicts clinical worsening at 1 year [sensitivity 99%, specificity 72%, area under the curve (AUC) 0.86 (95% confidence interval, CI: 0.67-1)]. In GBS, peak levels of plasma periaxin and the ratio of periaxin to axonal biomarkers [neurofilament light chain (NfL) and peripherin] discriminate most cases of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) from acute motor axonal neuropathy (AMAN), as classified by electrophysiology (sensitivity 100%, specificity 86%, AUC = 0.94, 95% CI: 0.81-1). Serial measurements showed that plasma periaxin levels peak 2 to 3 weeks after GBS symptom onset, followed by a gradual decline in the weeks thereafter. In vitro, periaxin is higher following immune-mediated demyelination compared with axonal damage and control conditions. Plasma periaxin is a biomarker of peripheral nerve demyelination. Combined with axonal fluid biomarkers and existing clinical scales, periaxin has the potential to improve the clinical management of peripheral neuropathies, accelerating advances in care and experimental research.
Publicações recentes
Acute Inflammatory Demyelinating Polyradiculoneuropathy-like Associated with Subcutaneous Foslevodopa-Foscarbidopa: First Report.
Case Report: Complete remission of Guillain-Barré syndrome in neuropsychiatric lupus with telitacicept.
Early Sensory-Predominant Guillain-Barré Syndrome With Normal Cerebrospinal Fluid and MRI Findings: A Diagnostic Challenge.
Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy in Pregnancy: A Rare Multisystem Presentation.
Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.
📚 EuropePMC41 artigos no totalmostrando 151
Acute Inflammatory Demyelinating Polyradiculoneuropathy-like Associated with Subcutaneous Foslevodopa-Foscarbidopa: First Report.
Movement disorders : official journal of the Movement Disorder SocietyCase Report: Complete remission of Guillain-Barré syndrome in neuropsychiatric lupus with telitacicept.
Frontiers in immunologyEarly Sensory-Predominant Guillain-Barré Syndrome With Normal Cerebrospinal Fluid and MRI Findings: A Diagnostic Challenge.
CureusSystemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy in Pregnancy: A Rare Multisystem Presentation.
CureusAxonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.
Pediatric neurologyBilateral Medial Medulla Infarct Mimicking a Neuromuscular Emergency.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiquesClinical Spectrum and Prognostic Predictors of Guillain-Barré Syndrome: A Prospective Observational Study From South India.
CureusAn Uncommon Presentation of Guillain-Barré Syndrome in a Young Postpartum Woman.
CureusGuillain-Barré Syndrome as the Initial Clinical Manifestation of Hodgkin's Lymphoma.
European journal of case reports in internal medicinePeripheral nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndrome.
bioRxiv : the preprint server for biologyPolyradiculoneuropathies associated with immune checkpoint inhibitors: are we facing a new nosological entity?
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyPlasma periaxin is a biomarker of peripheral nerve demyelination.
Brain : a journal of neurologyEvaluation and Comparison of Treatment Response and In-Hospital Prognosis of COVID-19-Related Guillain-Barre Syndrome with Non-COVID-19 Patients.
Medical journal of the Islamic Republic of IranGuillain-Barré Syndrome Induced by Mycoplasma Pneumoniae: A Non-classical Presentation.
CureusAltered Cellular Pathways in the Blood of Patients With Guillain-Barre Syndrome.
Journal of the peripheral nervous system : JPNSOnset of Guillain Barré Syndrome in a Pregnant Woman: A Report of a Rare Occurrence.
CureusPredictors of the Short-Term Outcomes of Guillain-Barré Syndrome: Exploring Electrodiagnostic and Clinical Features.
Brain and behaviorAn Uncommon Presentation of Guillain-Barré Syndrome With Lhermitte Sign.
CureusThe Initial Clinical and Electrophysiological Characteristics of Different Subtypes of Guillain-Barré Syndrome Diagnosed Based on Serial Electrophysiological Examinations.
Brain and behaviorTemporal Pattern of Individual Neurological Function Recovery in Guillain-Barré Syndrome.
Journal of clinical medicineGuillain-Barrè Syndrome-Retrospective Analysis of Data from a Cohort of Patients Referred to a Tertiary Care Pediatric Neuromuscular Center from 2000 to 2017: Electrophysiological Findings, Outcomes, and a Brief Literature Review.
Medicina (Kaunas, Lithuania)Complex Neurological Sequelae: Axonal Guillain-Barré Syndrome Post COVID-19 in a Young Patient.
CureusUnraveling the neurological intricacies: a rare case of Guillain-Barre syndrome in dengue fever.
Oxford medical case reportsExpanding our understanding of Guillain-Barré syndrome: Recent advances and clinical implications.
European journal of immunologyManagement of Severe Pain in a Case of Sensory Guillain-Barre Syndrome.
CureusMultiple cerebral infarctions after intravenous immunoglobulin for Guillain-Barré syndrome: two case reports and review of the literature.
Frontiers in immunologyAnimal models of immune-mediated demyelinating polyneuropathies.
AutoimmunityGuillain-Barré syndrome: History, pathogenesis, treatment, and future directions.
European journal of neurologyThe sural-sparing pattern in clinical variants and electrophysiological subtypes of Guillain-Barré syndrome.
Arquivos de neuro-psiquiatriaRehabilitation of a 51-Year-Old Patient With Miller Fisher Syndrome: A Case Report.
CureusGuillain-Barre syndrome of acute motor axonal neuropathy (AMAN) type associated with herpes zoster: a case report.
BMC neurologyGuillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Clinical neurology and neurosurgeryAggressive Acquired Demyelinating Neuropathy Caused by NF-155: Initially Treatment-Resistant.
Journal of clinical neuromuscular diseaseGuillain-Barré Syndrome Associated with SARS-CoV-2 in Two Pediatric Patients.
Sultan Qaboos University medical journalIncidence of Guillain-Barré syndrome in the world between 1985 and 2020: A systematic review.
Global epidemiologyPlasmapheresis Versus Intravenous Immunoglobulin in Patients With Autoimmune Neuromuscular and Neuro-immunological Conditions.
Journal of clinical neuromuscular diseaseAcute/chronic inflammatory polyradiculoneuropathy.
Handbook of clinical neurologyClinical characteristics and management outcomes of Guillain-Barré syndrome: eight-year experience at a tertiary center in jordan - a retrospective cohort study.
Annals of medicine and surgery (2012)Sympathetic skin response (SSR) in pediatric Guillain-Barré syndrome.
Frontiers in neurologyPathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies.
Brain pathology (Zurich, Switzerland)Principles of Therapeutic Apheresis in Neurological Disease.
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und ImmunhamatologieLeptomeningeal carcinomatosis presenting with acute motor axonal neuropathy.
Indian journal of cancerChanges in electrophysiological findings suggestive of demyelination following Guillain-Barré syndrome: A retrospective study.
Muscle & nerveGuillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
British journal of clinical pharmacologySpectrum of Neurological Complications Following COVID-19 Vaccination in India.
Journal of clinical neurology (Seoul, Korea)Prognostic Significance of Serial Nerve Conduction in GB Syndrome.
Neurology IndiaElevated monocyte to high-density lipoprotein cholesterol ratio correlates with clinical severity in acute inflammatory demyelinating polyradiculoneuropathy patients.
Frontiers in neurology[Guillain-Barré syndrome and other autoimmune neurophaties: current therapy].
MedicinaAssessment of neurological sequelae and new-onset symptoms in the long-term follow-up of paediatric Guillain-Barre syndrome: A longitudinal study from India.
Journal of paediatrics and child healthPembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy.
CureusA case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination.
Turkish journal of physical medicine and rehabilitationOutcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course.
European journal of neurologyCOVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
Journal of the neurological sciencesGuillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
Revista medica de ChileNeurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination.
CureusPost-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies.
Case reports in neurological medicineSerum thyroid-stimulating hormone is an independent risk factor of recurrent Guillain-Barré syndrome.
Muscle & nerveCOVID-19 Infection and Guillain-Barre Syndrome: A Case Series.
CureusLate-Onset Guillain-Barré Syndrome and Right Facial Nerve Palsy after COVID-19 Infection.
Case reports in neurologyCOVID-19-Induced Guillain-Barré Syndrome.
CureusImmunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.
Journal of clinical apheresisGuillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyCovid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
Diabetes & metabolic syndromeGuillain-Barre syndrome during COVID-19 pandemic: experience from a referral healthcare center in Mexico.
Revista de neurologiaAcute Inflammatory Demyelinating Polyneuropathy With Bowel and Bladder Incontinence Following COVID-19 Infection.
CureusBilateral Facial Palsy and Hyperreflexia as the Main Clinical Presentation in Guillain-Barré Syndrome.
The American journal of case reportsRelationship between cerebrospinal fluid protein level and electrophysiologic abnormalities in the acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barré syndrome.
German medical science : GMS e-journalIncidence and clinical characteristics of Guillain-Barré syndrome in Osona (Barcelona, Spain), 2003-2016.
NeurologiaDevelopment of Acute Inflammatory Demyelinating Polyneuropathy 11 Days after Spinal Surgery: A Case Report and Literature Review.
Case reports in medicineEpidemiological and clinical aspects of Guillain-Barré syndrome and its variants.
Arquivos de neuro-psiquiatriaClinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
BMC neurologyCase Report: Guillain-Barré Syndrome Associated With COVID-19.
Frontiers in neurologyTherapeutic plasma exchange in neurological diseases: Eleven years experience at a tertiary care center in Turkey.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyGuillain-Barré Syndrome With a Peculiar Course: A Case Report.
CureusElectrophysiological characteristics of patients with nitrous oxide abuse.
Neurological researchFunctional Impairments and Rehabilitation Outcomes of Patients With Immunotherapy-Induced Acute Inflammatory Demyelinating Polyradiculoneuropathy, Myasthenia Gravis, and Myositis.
American journal of physical medicine & rehabilitationClinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation.
Frontiers in neurologyElectrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection.
Neurophysiologie clinique = Clinical neurophysiologyImmune-mediated neuromuscular complications of graft-versus-host disease.
Muscle & nerveCreutzfeldt-Jakob Disease May Present Early With Unusual Bulbar Predominance.
The neurologistFrequency of Autonomic Dysfunction in Patients of Guillain Barre Syndrome in a Tertiary Care Hospital.
CureusLate onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of 'long COVID-19 syndrome'?
BMJ case reportsGuillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series.
Journal of the neurological sciencesCSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Journal of neurology, neurosurgery, and psychiatryAcute inflammatory demyelinating polyradiculoneuropathy following deep brain stimulator lead placement - Case report and review of the literature.
Clinical neurology and neurosurgeryCOVID-19: A Review for the Pediatric Neurologist.
Journal of child neurologyIs Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyClinical Characteristics and Electrodiagnostic Features of Guillain-Barré Syndrome Among the Pediatric Population.
Journal of child neurologyClinical, electrophysiological findings and evaluation of prognosis of patients with Guillain-Barré syndrome.
The Turkish journal of pediatricsRecurrent Guillain-Barré Syndrome - Case Series.
Neurology IndiaGuillain-Barré syndrome: clinical features, treatment choices and outcomes in an Australian cohort.
Internal medicine journalPrognostic factors for the sequelae and severity of Guillain-Barré syndrome in children.
Muscle & nerveClinical and electrophysiological characteristics of Guillain-Barré syndrome in Colombia.
Journal of the peripheral nervous system : JPNSDysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes.
Neurocritical careNivolumab and Ipilimumab-induced Acute Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report.
Journal of immunotherapy (Hagerstown, Md. : 1997)Coincidence of Guillain-Barré syndrome presenting with Landry's acute flaccid paralysis and transverse myelitis.
ReumatologiaPostoperative Guillain-Barré Syndrome, a Neurologic Complication that Must Not Be Overlooked: A Literature Review.
World neurosurgeryTherapeutic apheresis in neurological, nephrological and gastrointestinal diseases.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for HaemapheresisRole of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care SocietiesDry Beriberi Due to Thiamine Deficiency Associated with Peripheral Neuropathy and Wernicke's Encephalopathy Mimicking Guillain-Barré syndrome: A Case Report and Review of the Literature.
The American journal of case reportsGuillain-Barré syndrome as a complication of hypertensive basal ganglia haemorrhage.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaAtypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy.
Journal of child neurologyThe effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.
Drug design, development and therapySystematic review of factors associated with the development of Guillain-Barré syndrome 2007-2017: what has changed?
Tropical medicine & international health : TM & IHIncreased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up study.
Journal of the peripheral nervous system : JPNSThe electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand?
Clinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologyAntibodies to Zika virus, Campylobacter jejuni and gangliosides in Guillain-Barre syndrome: A prospective single-center study from southern India.
Neurology IndiaEpidemiology and Clinical Features of Guillain-Barre Syndrome in Isfahan, Iran.
Advanced biomedical researchMotor Nerve Conduction Block Predicting Outcome of Guillain-Barre Syndrome.
Frontiers in neurologyClinical Significance of A Waves in Acute Inflammatory Demyelinating Polyradiculoneuropathy.
Journal of clinical neurophysiology : official publication of the American Electroencephalographic SocietyPeripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence.
Clinical and experimental rheumatologyPatient with Guillain-Barré Syndrome with Posterior Spinal Root Involvement: A Case Report.
Sisli Etfal Hastanesi tip bulteniGuillain-BarrÉ syndrome subtype diagnosis: A prospective multicentric European study.
Muscle & nerveClinical and nerve conduction features in Guillain-Barré syndrome associated with Zika virus infection in Cúcuta, Colombia.
European journal of neurologyOutcome of Guillain-Barré Syndrome in Tertiary Care Centers in Thailand.
Journal of clinical neuromuscular diseaseEarly electrophysiological findings in acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barre syndrome in the Pakistani population - a comparison with global data.
Journal of the peripheral nervous system : JPNSProspective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barré syndrome in India.
Muscle & nerveWorsening Guillain-Barré syndrome: harbinger of IRIS in HIV?
BMJ case reports[Lower urinary tract dysfunction in Guillain-Barre syndrome].
Der Urologe. Ausg. AAcute Inflammatory Demyelinating Polyradiculoneuropathy Secondary to Ifosfamide.
American journal of therapeuticsHepatitis E virus and neurological disorders.
Practical neurologyThree cases of acute distal demyelinating neuropathy with recovery.
Clinical case reportsOptimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis.
Clinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologyAnalysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barré syndrome.
Clinica chimica acta; international journal of clinical chemistryOutcome of Guillain - Barré Syndrome in Children: A prospective cohort study in a tertiary hospital in Upper Egypt.
Electronic physicianPrevalence of autonomic dysfunction in hospitalized patients with Guillain-Barré syndrome.
Muscle & nerveDifferentiating Familial Neuropathies from Guillain-Barré Syndrome.
Pediatric clinics of North AmericaCo-Cccurrence of Guillain-Barre Syndrome and Primary Sjögren Syndrome in an Elderly Woman.
Acta neurologica TaiwanicaThe pathogenic relevance of αM-integrin in Guillain-Barré syndrome.
Acta neuropathologicaAnalysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barré syndrome.
Arquivos de neuro-psiquiatriaPediatric Miller Fisher Syndrome Complicating an Epstein-Barr Virus Infection.
Pediatric neurologyNivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Japanese journal of clinical oncologyPrognosis of Guillain-Barré Syndrome in Children.
Iranian journal of child neurologyAcute inflammatory demyelinating polyradiculoneuropathy in a newborn infant.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology SocietyAcute Motor Axonal Neuropathy (Aman) With Motor Conduction Blocks In Childhood; Case Report.
Iranian journal of child neurologySupernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
NeurologyAcute Bilateral Phrenic Neuropathy: from Diabetes Mellitus to Focal Guillain-Barré Syndrome.
MaedicaA comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Therapeutic advances in neurological disordersAlternating ptosis associated with asialo-GM1 and GD1b antibodies.
The International journal of neuroscience[Facial diplegia as unusual variant of Guillain-Barré syndrome: first case reported in Venezuela].
Investigacion clinica[Pathology of the Peripheral Nervous System in Guillain-Barré Syndrome].
Brain and nerve = Shinkei kenkyu no shinpoSural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Clinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologyGuillain-Barré syndrome: clinical profile and management.
German medical science : GMS e-journalInflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.
Acta neuropathologicaPupils in Acute Inflammatory Demyelinating Polyradiculoneuropathy Different From Adies Pupils.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiquesSevere acute inflammatory demyelinating polyradiculoneuropathy with persistent weakness associated with tumor-like nerve root enlargement.
Journal of clinical neuromuscular diseaseAcute Onset of Guillain-Barré Syndrome After Elective Spinal Surgery.
World neurosurgeryPeripheral neuropathies due to systemic lupus erythematosus in China.
MedicineGuillain-Barré syndrome (demyelinating) six weeks after bariatric surgery: A case report and literature review.
Obesity research & clinical practicePediatric Guillain-Barré syndrome: Indicators for a severe course.
Annals of Indian Academy of NeurologyGuillain-barré syndrome: a clinical study of twenty children.
Journal of clinical and diagnostic research : JCDRAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Polirradiculoneuropatia inflamatória aguda (aidp).
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Polirradiculoneuropatia inflamatória aguda (aidp)
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.
- Case Report: Complete remission of Guillain-Barré syndrome in neuropsychiatric lupus with telitacicept.
- Acute Inflammatory Demyelinating Polyradiculoneuropathy-like Associated with Subcutaneous Foslevodopa-Foscarbidopa: First Report.Movement disorders : official journal of the Movement Disorder Society· 2026· PMID 41748281mais citado
- Polyradiculoneuropathies associated with immune checkpoint inhibitors: are we facing a new nosological entity?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2025· PMID 41021157mais citado
- Plasma periaxin is a biomarker of peripheral nerve demyelination.
- Early Sensory-Predominant Guillain-Barré Syndrome With Normal Cerebrospinal Fluid and MRI Findings: A Diagnostic Challenge.
- Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy in Pregnancy: A Rare Multisystem Presentation.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:98916(Orphanet)
- MONDO:0020347(MONDO)
- GARD:16873(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q55346105(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
